SATT AxLR
SATT AxLR
Governance
Services for companies
Annual reports
Assisting you
Researchers
Call-for-projects
Companies
Startups
Practical guide
Technology offerings
Invest
In our technologies
In our startups
Technologies
Startups
AxLR TV
Working with AxLR
Purchasing & public procurement
Join us
Our startups are hiring
Media
News
Agenda
Press kit
Communication kit
Contact
✕
Home
Available technology
AVAILABLE TECHNOLOGY | Rare disease – Adult T-cell Leukemia (ATL) – HTLV-1
HTLV-1
En savoir +
HTLV-1
0
AVAILABLE TECHNOLOGY | Rare disease – Adult T-cell Leukemia (ATL) – HTLV-1
NANO4SCHIZO
En savoir +
NANO4SCHIZO
0
AVAILABLE TECHNOLOGY | Nanobody – Schizophrenia – mGlu2
IMIQUALINES
En savoir +
IMIQUALINES
5
AVAILABLE TECHNOLOGY | cancer – imiqualines
LipoSTAR
En savoir +
LipoSTAR
4
AVAILABLE TECHNOLOGY | Lipophenols – Carbonyl and oxidative stresses – MMP-9
SPIMA
En savoir +
SPIMA
3
AVAILABLE TECHNOLOGY | Stapled Peptides – Inflammatory diseases – Oncology
TIX001
En savoir +
TIX001
0
AVAILABLE TECHNOLOGY | Prevention of the toxicity of DNA-damaging anti-cancer agents – Chemotherapy and radiotherapy – Improvement of anti-cancer treatment efficacy
TESOVIR
En savoir +
TESOVIR
0
AVAILABLE TECHNOLOGY | HIV Reservoir – Biomarkers – mAb
LRAs
En savoir +
LRAs
0
AVAILABLE TECHNOLOGY | HIV – Shock & Kill Strategy – LRAs
PSYMAGES
En savoir +
PSYMAGES
0
TECHNOLOGIE AVAILABLE | Iconography – Mental imaging – Education and therapeutic compliance
1
2
3
4
Suivant